About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tamalintm1.1Nak
targeted mutation 1.1, Shigetada Nakanishi
MGI:3723519
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Tamalintm1.1Nak/Tamalintm1.1Nak B6.129S-Tamalintm1.1Nak MGI:3757984


Genotype
MGI:3757984
hm1
Allelic
Composition
Tamalintm1.1Nak/Tamalintm1.1Nak
Genetic
Background
B6.129S-Tamalintm1.1Nak
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tamalintm1.1Nak mutation (0 available); any Tamalin mutation (15 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• during the acute phase of morphine-induced hyperlocomotion, there is a reduced in distance traveled by mice compared to wild-type mice at 2.5 mg/kg and 5 mg/kg but not 10 mg/kg of morphine
• however, morphine antinociceptive tolerance and morphine withdrawal effects on mice are unaltered
• conditioned place preference is reduced at 3 mg/kg morphine
• mice treated with 10mg/kg morphine and subjected to a hotplate test exhibit decreased analgesic response to morphine relative to wild-type mice during the first 40 minutes
• however, the duration of morphine's analgesic effect was unchanged (about 90 minutes) and there is no differences in morpholino maximal possible effect in a tail-flick test are observed
• the maximal possible effect of 10 mg/kg morphine is decreased relative to wild-type but unchanged at 20 mg/kg





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory